Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology
Link
https://link.springer.com/content/pdf/10.1007/s12026-022-09283-y.pdf
Reference40 articles.
1. Cantini F, Goletti D, Petrone L, Najafi Fard S, Niccoli L, Foti R. Immune therapy, or antiviral therapy, or both for COVID-19: a systematic review. Drugs. 2020;80:1929–46.
2. Goletti D, Cantini F. Baricitinib Therapy in Covid-19 Pneumonia - an unmet need fulfilled. N Engl J Med. 2021;384:867–9.
3. Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B. Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity. Int JMol Sci. 2020;21:3330.
4. Agrati C, Castilletti C, Goletti D, et al. Coordinate induction of humoral and spike specific t-cell response in a cohort of Italian health care workers receiving BNT162b2 mRNA Vaccine. Microorganisms. 2021;9:1315.
5. Angyal A, Longet S, Moore S, et al. T-Cell and antibody responses to first BNT162b2 Vaccine dose in previously SARS-CoV-2-infected and infection-naive UK Healthcare Workers: a multicentre, prospective, observational cohort study. Lancet Microbe. 2022;3:e21–31.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA);Microbiology Spectrum;2024-04-02
2. Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients;Kidney International Reports;2023-09
3. Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy;Biomedicines;2023-08-29
4. Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients;Rheumatology;2023-06-08
5. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA);Vaccine;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3